TrialCancer immunology, immunotherapy : CII2025

Ex vivo-expanded and activated haploidentical natural killer cells infusion before autologous stem cell transplantation in high-risk neuroblastoma: a phase I/II pilot study.

Tahereh Rostami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.